Medicine
Hyftor 0.2% gel
Hyftor 0.2% gel is a prescription medicine containing Sirolimus for topical use, marketed by Nobelpharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store refrigerated at 2° to 8°C (36° to 46°F). Protect from light.
Key facts
- Active ingredient (INN)
- Sirolimus
- Brand
- Hyftor
- Strength
- 0.2%
- Dosage form
- Gel
- Route
- Topical
- Packs
- 1 tube
- Marketing authorisation holder
- Nobelpharma
- Manufacturer
- Nobelpharma
- Origin register
- US FDA, United States
- Storage
- Store refrigerated at 2° to 8°C (36° to 46°F). Protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AH01 Sirolimus
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 March 2022
- Identifiers
- RxCUI 2596864, 2596869DailyMed set ID edb3ea90-5adc-48ec-99f5-ab963e302f18NDC 73683-101Application NDA213478
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 10 g in 1 tube | 73683-101-10 | Nobelpharma | 23 March 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sirolimus
Clinical summary
Sirolimus is a kinase inhibitor indicated for the prophylaxis of organ rejection in patients aged ≥13 years receiving renal transplants, among other approved uses. MedsAcross supplies Sirolimus for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SirolimusFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sirolimus prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Hyftor: European public assessment report (EPAR) · European Medicines Agency
- Rapamune: European public assessment report (EPAR) · European Medicines Agency
Need Hyftor 0.2% gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.